AllCancer | Advanced Cancer Treatment Centre

AllCancer Hong Kong metabolic cancer treatment centre

Home/ About AllCancer LLC

Pioneering Metabolic Cancer Treatment

Hong Kong Metabolic Oncology Center

AllCancer, a division of All Cancer Medical Solutions Limited, leads the charge in metabolic cancer treatment, harnessing global expertise and cutting-edge technology to transform lives. Our mission is to make cancer a manageable condition, empowering patients with hope and dignity.

We Aim To Cure All Cancer

Our Mission & Vision

At AllCancer, we believe cancer should not be a life sentence but a new starting point for health management. Our ambitious goals drive us to push the boundaries of oncology.

01

Transforming Hope

By 2025, we aim to include 20 cancer types in a chronic disease management framework, enabling patients to live fulfilling lives alongside their condition.

02

Breaking Survival Limits

By 2030, we strive for a 90% five-year survival rate for advanced-stage patients, surpassing the current global benchmark of less than 35%.

03

Holistic Care Ecosystem

We build a comprehensive care model, integrating prevention, treatment, and rehabilitation to support patients throughout their journey.

AllCancer mission to cure and manage cancer as a chronic condition

Who We Are

We Are Always Open For Your Hopes

AllCancer, under the Hong Kong Metabolic Oncology Center, is a global pioneer in metabolic cancer treatment. We unite over 150 experts from the Greater Bay Area, including biologists, oncologists, molecular scientists, clinicians, pathologists, and more, to deliver the revolutionary International Four-Dimensional Therapy.

This innovative approach integrates four patented dimensions: Metabolic Reprogramming, Dual Immune Modulation, Smart Nano-Targeting, and Tumor Microenvironment Remodeling. With over 12,000 treated cases, including 4,129 in global randomized controlled trials (NCT04820250113), our therapy achieves a 68.7% objective response rate for advanced patients – 228% higher than traditional treatments, as published in Nature Medicine.

Our global reach includes clinical adoption by prestigious hospitals like Shenzhen Qianhai Taikang Hospital and Shanghai International Medical Center, with international bases in Boston and Berlin, serving patients across Asia-Pacific and Europe.

Our Treatment Philosophy

Only Deliver What’s Best For Our Cancer Patients

At AllCancer, we redefine cancer care by transcending the limitations of traditional chemotherapy, radiotherapy, and surgery. Our holistic, full-lifecycle management approach integrates precision targeting of cancer’s metabolic dependencies, optimization of the body’s repair mechanisms, and activation of immune defenses. This multi-dimensional strategy not only addresses the cancer itself but also supports the patient’s overall health, aiming to transform cancer into a manageable chronic condition rather than a terminal illness.

The cornerstone of our treatment is the International Four-Dimensional Therapy, which uniquely combines:

AllCancer oncology experts and Nobel laureates team

Methodology Contributors

Nobel-Led Scientific Alliance

International research and clinical collaboration continue to inform the programme’s methodology.

Dr. Gregg L. Semenza

2019 Nobel Laureate in Physiology or Medicine

Dr. Gregg L. Semenza

Prof. Ali Mahommed Bin

Founding Director of Prince of Wales Hospital

Prof. Ali Mahommed Bin

Dr. James P. Allison

2018 Nobel Laureate in Physiology or Medicine

Dr. James P. Allison

Prof. Guolong Liu

Pioneer in Refractory Tumor Integrated Therapy

Prof. Guolong Liu

Metabolic reprogramming, nano targeting and immune modulation diagram

Research and Innovation

AllCancer: Where Metabolic Science Leads the Way

At AllCancer, we are committed to pushing the boundaries of cancer research and treatment. Our team of over 150 experts from 17 countries collaborates to develop and refine our metabolic cancer therapies.

We have published groundbreaking research in prestigious journals like Nature Medicine, demonstrating the efficacy of our therapies. Our clinical trials, such as NCT04820250113, have shown remarkable results, with objective response rates significantly higher than those of traditional treatments.

Moreover, our therapies are protected by patents in the US, EU, China, and Japan, ensuring that our innovative approaches are at the forefront of global cancer care.

Patient Care and Support

AllCancer: Your Partner in Healing

We understand that a cancer diagnosis affects not just the patient but their entire family. That is why we offer comprehensive support services, including:

Our goal is to provide a supportive environment where patients can focus on their recovery with peace of mind.

AllCancer global reach and patient support network

Book an Appointment

Join Us in the Fight Against Cancer

Discover how AllCancer’s innovative therapies can transform your cancer journey. Contact us today for a personalized consultation and take the first step toward hope and healing.

Scroll to Top